scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
February 11, 2021 08:00 ET
|
scPharmaceuticals, Inc.
BURLINGTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
scPharmaceuticals Inc. Receives Complete Response Letter from FDA for FUROSCIX®
December 07, 2020 08:00 ET
|
scPharmaceuticals, Inc.
BURLINGTON, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
scPharmaceuticals to Present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference
November 19, 2020 08:00 ET
|
scPharmaceuticals, Inc.
BURLINGTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
scPharmaceuticals Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update
November 16, 2020 07:00 ET
|
scPharmaceuticals, Inc.
Commercialization preparedness activities continuing ahead of December 30 PDUFA date for FUROSCIX® (furosemide injection) for subcutaneous administration Enrolled first patient in FREEDOM-HF...
scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
November 11, 2020 08:00 ET
|
scPharmaceuticals, Inc.
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...